RE/MAX (RMAX) Form 144: 9,100 shares from 2019 grants to be sold
Rhea-AI Filing Summary
RE/MAX Holdings (RMAX) filed a Form 144 notifying the proposed sale of 9,100 common shares with an aggregate market value of $85,267.31. The shares were acquired as stock grants on 06/12/2019 and the filer reports no sales in the prior three months. The filing lists the sale as to occur on 09/30/2025 on the NYSE, against a reported shares outstanding base of 20,029,994. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information and references potential trading-plan disclosures under Rule 10b5-1.
Positive
- Transparent disclosure of proposed sale amount: 9,100 shares worth $85,267.31
- Securities were acquired via stock grants on 06/12/2019, indicating vested compensation rather than new external financing
- No reported sales in the past three months for the selling account
Negative
- None.
Insights
Small, disclosed insider sale from vested stock grants; unlikely to move markets.
The filing shows an insider intends to sell $85,267.31 worth of stock—0.045% of the reported 20,029,994 shares outstanding—originating from 06/12/2019 stock grants. Such sales commonly reflect routine monetization of vested awards rather than corporate news.
Primary risks include timing concentration if multiple insiders sell near 09/30/2025, which could create temporary selling pressure. Watch for any additional Form 144s or trading-plan disclosures in the next 30–90 days.